TAK
TAK clinical trials: TAKEDA PHARMACEUTICAL CO LTD
Every trial on ClinicalTrials.gov where TAKEDA PHARMACEUTICAL CO LTD is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 2,366
- Trials linked
- 1,692
- As lead sponsor
- 674
- As collaborator
- 14
- Primary completions as lead sponsor, next 90 days
TAK on the catalyst calendar · TAK registry changes
- Primary completion May 1, 2027Sponsor estimatePhase 4NCT06581328A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community SettingTakeda · Ulcerative ColitisRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 12, 2030Sponsor estimatePhase 3NCT06405087A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)Takeda · Ulcerative ColitisRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 11, 2028Sponsor estimatePhase 3NCT06980480A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple MyelomaTakeda · Multiple MyelomaRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 18, 2029Sponsor estimatePhase 3NCT07286058Continuation Study of Zasocitinib in Adults With Psoriatic ArthritisTakeda · Psoriatic ArthritisRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 3, 2034Sponsor estimatePhase 3NCT07250802A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisTakeda · Plaque PsoriasisRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 18, 2027Sponsor estimatePhase 3NCT06671483A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesTakeda · Psoriatic ArthritisActive, not recruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 1, 2026ActualNo phase registeredNCT06677892A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in BelgiumTakeda · Cytomegalovirus (CMV)CompletedTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 27, 2026ActualNo phase registeredNCT05397431A Survey of Lanadelumab in Participants With Hereditary AngioedemaTakeda · Hereditary Angioedema (HAE)CompletedTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2029Sponsor estimateNo phase registeredNCT05113095A Survey of Darvadstrocel in People With Crohn's DiseaseTakeda · Crohn's DiseaseRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 26, 2028Sponsor estimatePhase 3NCT06165341Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring...Takeda · Alpha1-Antitrypsin DeficiencyRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2, 2033Sponsor estimatePhase 3NCT05899673An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver...Takeda · Alpha1-Antitrypsin DeficiencyActive, not recruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 7, 2029Sponsor estimatePhase 3NCT07623161A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking RuxolitinibTakeda · MyelofibrosisRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2029Sponsor estimatePhase 3NCT07422480A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need...Takeda · Myelodysplastic SyndromeRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2030Sponsor estimateNo phase registeredNCT07353099A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With AdzynmaTakeda · Thrombotic Thrombocytopenic Purpura (TTP)RecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 15, 2028Sponsor estimatePhase 3NCT06499285A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need...Takeda · Myelodysplastic SyndromesRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 15, 2031Sponsor estimatePhase 2/Phase 3NCT07646678A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaTakeda · Idiopathic HypersomniaRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 3, 2026ActualNo phase registeredNCT07263685A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi ArabiaTakeda · Hereditary Angioedema (HAE)CompletedTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2028Sponsor estimateNo phase registeredNCT06550882A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South KoreaTakeda · Acquired Hemophilia ARecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 30, 2027Sponsor estimatePhase 3NCT07752108A Study of Zasocitinib in Adults With Non-pustular Palmoplantar PsoriasisTakeda · Palmoplantar PsoriasisNot yet recruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 15, 2029Sponsor estimatePhase 2NCT07613359A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney TransplantTakeda · Antibody-Mediated Rejection (AMR)RecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 5, 2027Sponsor estimatePhase 2NCT07244263A Study of Zasocitinib in Adults With Hidradenitis SuppurativaTakeda · Hidradenitis SuppurativaActive, not recruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 7, 2028Sponsor estimatePhase 3NCT06963827A Study of Mezagitamab in Adults With Kidney Condition Called IgA NephropathyTakeda · Kidney DiseaseRecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 16, 2028Sponsor estimatePhase 3NCT06722235A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaTakeda · Immune Thrombocytopenic Purpura (ITP)RecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 1, 2028Sponsor estimateNo phase registeredNCT06555432A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South KoreaTakeda · Cytomegalovirus (CMV)RecruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 26, 2027Sponsor estimatePhase 2NCT07108283A Study of Zasocitinib in Adults With Nonsegmental VitiligoTakeda · Nonsegmental VitiligoActive, not recruitingTAKLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 2,341 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner